DPP® Zika IgM Assay System

The Chembio DPP Zika IgM Assay System is a rapid test designed to detect IgM Antibodies to Zika virus in fingerstick whole blood, EDTA, venous whole blood, EDTA plasma and serum.

Key features:

• 15-minute rapid Zika test providing immediate results
• Wide testing window (8 days to 12 weeks) from onset of symptoms; better chance of detecting exposure to Zika virus
• Digital reader (DPP® Micro Reader) offers objective results, eliminating subjective visual interpretation

Product Details and Ordering

*IMPORTANT:

• The test has not been FDA cleared or approved.
• The test has been authorized by FDA under an EUA for use by authorized laboratories.
• The test has been authorized only for the diagnosis of Zika virus infection and not for any other viruses or pathogens.
• The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of the Zika virus and /or diagnosis of Zika virus infection under section 564(b)(1) of the Act 21 U.S.C. §360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.